MindMed is now Definium Therapeutics, a rebrand that reflects our commitment to forging a new era of psychiatry by applying precision to psychedelic medicine. Follow our new page at the link below!
Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.
We further our mission by:
● Developing psychedelics and marijuana into prescription medicines
● Training therapists and working to establish a network of treatment centers
● Supporting scientific research into spirituality, creativity, and neuroscience
● Educating the public honestly about the risks and benefits of psychedelics and marijuana